Novo Nordisk AS
NVO · NYSE · Pharmaceuticals, Biotech · Founded 1923
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Current Price
$39.14
Market Cap
$173B
Return Since Last Split
-24%
Last Split
Sep 20, 2023
Total Splits
5
Cumulative Multiple
200×
What If You Bought NVO Earlier?
Investment
Purchase Date (Before Split)
Worth Today
$782,800
20,000 shares · 200×
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Sep 20, 2023 | $93.53 | 2-for-1 | 2× | 200× |
| Jan 9, 2014 | $18.93 | 5-for-1 | 5× | 100× |
| Dec 17, 2007 | — | 2-for-1 | 2× | 20× |
| Apr 11, 2001 | — | 5-for-2 | 2.5× | 10× |
| Apr 18, 1994 | — | 4-for-1 | 4× | 4× |
Novo Nordisk AS Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 5 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.
Frequently Asked Questions
Novo Nordisk AS's latest record in the split calendar is a 2-for-1 forward split effective 2023-09-20.